title: Hypertension following kidney transplantation.
abstract: The majority of patients become hypertensive following kidney transplantation. Its occurrence is associated not only with increased fatal and nonfatal cardiovascular events but also with decreased allograft survival. This review summarizes the current knowledge of the epidemiology, etiology, pathophysiology, and management of post-transplant hypertension.
authors.affiliation: Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. mfrubin@partners.org
authors.forename: Mario F
authors.initials: MF
authors.lastname: Rubin
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D051799:Delayed Graft Function / Q000150:complications; D004035:Diet Therapy; D004232:Diuretics / Q000627:therapeutic use; D006084:Graft Rejection / Q000150:complications; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000150:complications; D006973:Hypertension / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000009:adverse effects*; D012078:Renal Artery Obstruction / Q000150:complications; D012307:Risk Factors
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D007166:Immunosuppressive Agents